This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Integrin β3 Antibody, clone BB10
catalog :
MAB1974
quantity :
50 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
BB10
The same clone is also sold as:
The same clone is also sold as:
- LifeSpan Biosciences: LS-C202520, LS-C123859
- Abnova: MAB2510
- OriGene: AM32082PU-N
reactivity :
human, pigs
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section
citations: 5
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
product information
Catalog Number :
MAB1974
Subcategory :
Cell Structure
Product Name :
Anti-Integrin β3 Antibody, clone BB10
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P05106
Host Name :
Mouse
Antigen :
Integrin β3
Clone :
BB10
Conjugate :
Purified
Isotype :
IgG1
Product Description :
Anti-Integrin β3 Antibody, clone BB10
Cross Reactivity :
Human
ALT Names :
CD61
Immunogen :
Partially purified platelet glycoprotein IIb/lIIa complex.
Specificity :
Reacts with the beta-3 subunit of the integrin family, including GPIIIa of platelets. Recognized an extracellular epitope of beta-3.
Package Size :
50 µg
Uses :
Western Blotting;Immunocytochemistry;Immunohistochemistry
Storage :
Maintain between 2 and 8°C up to 12 months.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments